Evaluation of the plasma microRNA levels in stage 3 premature retinopathy with plus disease: preliminary study.

Metin, T; Dinç, E; Görür, A; Erdogan, S; Ertekin, S; Sari, A A; Tamer, L; Çelik, Y

Metin, T; Dinç, E; Görür, A; Erdogan, S; Ertekin, S; Sari, A A; Tamer, L; Çelik, Y.

Affiliation

Metin T; Ophthalmology Clinic, Mersin State Hospital, Mersin, Turkey.
Dinç E; Faculty of Medicine, Department of Ophthalmology, Mersin University, Mersin, Turkey.
Görür A; Faculty of Medicine, Department of Biochemistry, Mersin University, Mersin, Turkey.
Erdogan S; Faculty of Medicine, Department of Biostatistics, Mersin University, Mersin, Turkey.
Ertekin S; Ophthalmology Clinic, Osmaniye State Hospital, Osmaniye, Turkey.
Sari AA; Faculty of Medicine, Department of Ophthalmology, Mersin University, Mersin, Turkey.
Tamer L; Faculty of Medicine, Department of Biochemistry, Mersin University, Mersin, Turkey.
Çelik Y; Faculty of Medicine, Division of Newborn, Mersin University, Mersin, Turkey.

Eye (Lond) ; 32(2): 415-420, 2018 02.

Article in En | MEDLINE | ID: mdl-28960215

Subject(s)

MicroRNAs/metabolism; Retinopathy of Prematurity/metabolism; Case-Control Studies; Female; Humans; Infant, Newborn; Infant, Premature; Male; MicroRNAs/blood; Real-Time Polymerase Chain Reaction

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Retinopathy of Prematurity / MicroRNAs Type of study: Clinical_trials / Observational_studies Limits: Female / Humans / Male / Newborn Language: En Year: 2018 Type: Article

Fulltext

XML

PubMed Links

Search on Google